cefixime has been researched along with Group A Strep Infection in 7 studies
Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In an open, controlled, randomized multicenter study, 160 children suffering from pharyngitis and/or tonsillitis were treated with either 8 mg cefixime/kg body weight once daily for 5 days or 20,000 I." | 9.08 | 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. ( Adam, D; Hostalek, U; Tröster, K, 1995) |
| "An open label randomized trial conducted in rural Kentucky compared the efficacy and safety of cefixime (CFX), 8 mg/kg once daily, with those of penicillin V (PEN), 250 mg 3 times daily, in 110 pediatric patients with Group A beta-hemolytic streptococcal pharyngitis." | 9.07 | Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. ( Block, SL; Hedrick, JA; Tyler, RD, 1992) |
| "In an open, controlled, randomized multicenter study, 160 children suffering from pharyngitis and/or tonsillitis were treated with either 8 mg cefixime/kg body weight once daily for 5 days or 20,000 I." | 5.08 | 5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group. ( Adam, D; Hostalek, U; Tröster, K, 1995) |
| "An open label randomized trial conducted in rural Kentucky compared the efficacy and safety of cefixime (CFX), 8 mg/kg once daily, with those of penicillin V (PEN), 250 mg 3 times daily, in 110 pediatric patients with Group A beta-hemolytic streptococcal pharyngitis." | 5.07 | Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. ( Block, SL; Hedrick, JA; Tyler, RD, 1992) |
| "6 microg/ml, respectively with 200 or 400 mg doses of cefditoren pivoxil; plasma concentrations exceed 1 microg/ml for 4 to 6 hours (33-50% of dosing interval)." | 1.31 | Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species. ( Beach, ML; Biedenbach, DJ; Johnson, DM; Jones, RN; Pfaller, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rush, C | 1 |
| Simon, MW | 1 |
| Adam, D | 1 |
| Hostalek, U | 1 |
| Tröster, K | 1 |
| Davies, HD | 1 |
| Low, DE | 1 |
| Schwartz, B | 1 |
| Scriver, S | 1 |
| Fletcher, A | 1 |
| O'Rourke, K | 1 |
| Ipp, M | 1 |
| Goldbach, M | 1 |
| Lloyd, D | 1 |
| Saunders, NR | 1 |
| de Lalla, F | 1 |
| Johnson, DM | 1 |
| Biedenbach, DJ | 1 |
| Beach, ML | 1 |
| Pfaller, MA | 1 |
| Jones, RN | 1 |
| Hamilton-Miller, JM | 1 |
| Block, SL | 1 |
| Hedrick, JA | 1 |
| Tyler, RD | 1 |
1 review available for cefixime and Group A Strep Infection
| Article | Year |
|---|---|
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemop | 2000 |
4 trials available for cefixime and Group A Strep Infection
| Article | Year |
|---|---|
The effect of amoxicillin-clavulanate, cefixime and azithromycin on normal throat flora in children with group A streptococcal pharyngitis.
Topics: Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Cefixime; Child; Child, Preschool; Dose | 2003 |
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Topics: Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicil | 1995 |
Evaluation of short-course therapy with cefixime or rifampin for eradication of pharyngeally carried group A streptococci. The Ontario GAS Study Group.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Child; Drug Administration Schedule; | 1995 |
Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents.
Topics: Adolescent; Cefixime; Cefotaxime; Child; Child, Preschool; Female; Humans; Male; Penicillin V; Phary | 1992 |
2 other studies available for cefixime and Group A Strep Infection
| Article | Year |
|---|---|
Cefixime in the treatment of upper respiratory tract infections and otitis media.
Topics: Cefixime; Cefotaxime; Cephalosporins; Humans; Otitis Media; Patient Compliance; Penicillin Resistanc | 1998 |
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Topics: Cefaclor; Cefixime; Cephalosporins; Gram-Negative Bacterial Infections; Haemophilus Infections; Haem | 2000 |